http://rdf.disgenet.org/resource/nanopub/NP363871.RAqLhC6O8XHPBzAV5Ou7ahtHXdC3Js_Owe3KtdGg7e3mU
type: Nanopublication
created: 2016-05-13T12:44:30+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

http://rdf.disgenet.org/resource/nanopub/NP363871.RAqLhC6O8XHPBzAV5Ou7ahtHXdC3Js_Owe3KtdGg7e3mU130_assertion
type: Assertion
description: [We investigated patients with APL receiving all-trans retinoic acid (ATRA) or arsenic trioxide (As(2)O(3)) treatment, contributing to the downregulation of the expression of annexin II on APL cells, and decreasing the generation of plasmin by tissue plasminogen activator (t-PA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/12165291
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0